Trial Profile
A retrospective, multi-center French study of Takayasu arteritis patients treated with tocilizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2018
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Takayasu syndrome
- Focus Therapeutic Use
- 16 Jul 2018 New trial record
- 16 Jun 2018 Results presented at the 19th Annual Congress of the European League Against Rheumatism